HIV Mutation Detail Information

> K101E Search Result


Mutation Information
Mutation Site K101E
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug lamivudine (LAM);tenofovir (TDF);efavirenz (EFV)
Country china
Literature Information
PubMed PMID 33122923
Disease HIV infection/AIDS
Published Year 2020
Journal Infection and drug resistance
Title Transmitted and Acquired HIV-1 Drug Resistance from a Family: A Case Study.
Author Yan L,Yu F,Zhang H,Zhao H,Wang L,Liang Z,Zhang X,Wu L,Liang H,Yang S,Tang Y,Zhang F
Evidence Mother also acquired K101E (41.03%), K103N (27.56%) and minor mutation of V106M (4.30%) after improperly discontinuing antiretroviral regimen of lamivudine (3TC), tenofovir (TDF) and efavirenz (EFV).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation